We examined the relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality after the occurrence of myocardial infarction in 766 patients who enrolled in a nine-hospital study and underwent two special tests. Frequency and repetitiveness of ventricular premature depolarizations (VPDs) were determined by computer analysis of predischarge 24 hr electrocardiographic recordings. The left ventricular ejection fraction (LVEF) was determined by radionuclide ventriculography and dichotomized at its optimal value of 30%. Frequency of VPDs was divided into three categories: (1) less than one per hour, (2) one to 2.9 per hour, and (3) three or more per hour. Repetitiveness of VPDs was also divided into three categories: (1) no repetitive VPDs, (2) paired VPDs, and (3) VPD runs. These variables were related, one at a time and jointly, to total mortality and to deaths caused by arrhythmias. The hazard ratios for dying in the higher or highest risk stratum vs the lower or lowest stratum for each variable (adjusted for the effects of the others) were: LVEF below 30%, 3.5; VPD runs, 1.9; and VPD frequency of three or more per hour, 2.0. There were no significant interactions among the three variables with respect to effects on the risk of mortality. There was a suggestion of an interaction between each risk variable and time after infarction. LVEF below 30% was a better predictor of early mortality (less than 6 months) and the presence of ventricular arrhythmias was a better predictor of late mortality (after 6 months). The results of this large multicenter study support the conclusion that ventricular arrhythmias and left ventricular dysfunction are independently related to mortality risk.
High frequency and various "complex" forms of ventricular arrhythmias have been proposed as the best predictors of subsequent mortality.'-' Of the complex forms, pairs and runs of three or more consecutive ventricular premature depolarizations (VPDs) have the strongest association with subsequent mortality.8 9 The relationship between ventricular arrhythmias and left ventricular dysfunction after myocardial infarction is a controversial issue. Two large studies have shown an independent effect of ventricular arrhythmias on mortality after adjustment is made for left ventricular dysfunction.3' 4 However, both studies used a short electrocardiogram (ECG) and clinical heart failure as the indicators of left ventricular dysfunction.
Other workers have concluded that ventricular arrhythmias are so strongly associated with left ventricular dysfunction that this association accounts for the relationship between ventricular arrhythmias and death. '°T he initial report from the Multicenter Post-Infarction Program presented our primary a priori analysis. 1 1 An average VPD frequency of greater than 10 per hour was used as the index of arrhythmia and ejection fraction less than 40% (determined by radionuclide ventriculography) was used as the index of left ventricular dysfunction. The a priori analysis showed a significant association between frequency of VPDs and mortality when adjustment was made for left ventricular dysfunction. Since our primary analysis dichotomized the variables at values selected before we examined the data, the relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality were not fully explored.
The purpose of this study is to define the interrelationships among frequency of VPDs, repetitiveness of VPDs, left ventricular dysfunction, and mortality in a large multicenter study. This information should help to establish strategies for detection of high-risk patients and to determine the feasibility of selected drug treatment (e.g., antiarrhythmic drugs) for secondary prevention.
Methods
Patients. Patients were selected from nine participating hospitals located in New York City, Rochester, NY, St. Louis, and Tucson. The diagnosis of a definite acute myocardial infarction required the presence of two of the following: (1) a clinical history of central chest pressure, pain, or tightness lasting 30 min or more, (2) ECG Q waves that fulfilled one of the major criteria for abnormal Q waves of the Minnesota ECG code2 with evolutionary ST and T wave changes on serial tracings, or (3) MB isoenzyme fraction greater than 4% of the total creatine kinase, or elevation of creatine kinase or aspartine transaminase levels greater than the upper limit of normal in the hospital laboratory for 2 days or more during the coronary care unit phase without other clinical reasons for the enzyme elevation. During the 2 year recruitment period (January 1, 1979, to December 31, 1980) , 4090 patients were screened and 1417 patients were eligible (i.e., had myocardial infarction and were under 70 years of age). Eligible patients were excluded from enrollment if they had life-threatening comorbidity or if they lived too far away for follow-up. Of the 1417 eligible patients, 866 lacked exclusion criteria and were enrolled after they signed written informed consent statements.
Follow-up. Enrolled patients had follow-up contact either by a clinical visit or by phone at 3, 6, and 12 months after infarction and then annually. The study design called for a common termination date (December 31, 1981) . Therefore follow-up ranged from 12 to 36 months; the average duration of follow-up was 22 months. Thirty-six patients (4.2%) were lost to follow-up during the study: 13 in the first year, 19 in the second year, and four in the third year.
Data acquisition. The 452 clinical variables collected for each patient included demographics, medical history, course of treatment in the coronary care unit, 12 lead ECG findings, left ventricular ejection fraction (LVEF), 24 hr ECG recording, a low-level predischarge treadmill exercise test,13 medical/cardiac status at discharge, and follow-up data on rehospitalization and mortality events through December 31, 1981 . Missing values in the routine clinical data were in the range of 0.5% or less. For the special tests analyzed in this study, 47 (5%) did not undergo a 24 hr ECG recording and 56 (6%) did not undergo 24 hr ambulatory ECGs were analyzed by computer with manual overread.'415 Holter ECG tapes were randomly assigned for computer analysis to either the Columbia University Arrhythmia Control Unit or to the Washington University Arrhythmia Analysis Laboratory.'4 5 Before the program began, the two laboratories demonstrated excellent agreement in their quantitative identification of VPD frequency and repetitiveness of VPDs. As part of ongoing quality-control procedures, 140 24 hr ECGs were selected at random by the data coordinating center for a second computer analysis. There were 77'crossreadings (Columbia University vs Washington University) and 63 repeat readings (by 'the same institution) over the duration of the study.
A two-way analysis of variance was used to assess the degree of bias between and within institutions for the computed frequency of VPDs. To measure degree of agreement for this quantitative variable, the intraclass correlation coefficient (ICC) was used.'6 An exact binomial version of McNemar's test for matched samples was used to test for bias in the detection of repetitive VPDs (defined as two or more VPDs in a row).'7 The kappa statistic was used as the measure of agreement for this dichotomous variable. 17 Kappa is interpreted in the same way as the ICC for quantitative data; however, values of kappa are lower for similar degrees of correlation. 17 For the repeat readings from each of the two centers and the crossreadings, there was no significant bias present for VPD frequency. The ICCs revealed excellent agreement for the intracenter and intercenter repeat readings for VPD frequency (ICC > .90 in each case). For VPD runs, the exact version of the McNemar test revealed no evidence of bias in the detection of repetitive VPDs. The kappa statistics showed very good agreement for the repeat reading's and crossreadings (kappa = .79 for the repeat readings on either system and kappa = .55 for the crossreadings). LVEF was measured by radionuclide ventriculography with patients in the supine position. The first-pass technique used a 20 to 30 degree right anterior oblique projection during acquisition of data, whereas the multiple-gated technique (MUGA) was performed in a 45 to 60 degree left anterior oblique projection. Quality-control procedures for the LVEF measurements have been described previously. " Mortality data. Detailed information was collected on the clinical circumstances surrounding each of the enrolled patients who died on or before December 31, 1981 . A four-member mortality committee classified each death as to geographic location, underlying cause, elapsed time between onset of acute cardiac symptoms and death, and the suspected mechanism of death in patients dying of atherosclerotic heart disease. Each death was classified by the method of Hinkle (sed table 1) as follows: deaths primarily due to arrhythmia, Hinkle class I; deaths primarily due to nonarrhythmic causes, Hinkle class II (circulatory failure); and deaths not classifiable, Hinkle class 111.18 The file containing the mortality data was closed to the investigators until the time of the primary analysis. For the present analysis, two mortality end points were used: death from any cause and potentially avoidable death due to arrhythmia (from the Hinkle classification). Because judgment has to be applied to classify deaths and because all the information pertinent to classification is almost never available, we used total mortality as the primary end point for analysis.
Statistical methods. The relationships among frequency of VPDs, repetitiveness of VPDs, and left ventricular dysfunction on one hand and total or arrhythmic (Hinkle class I) mortality on the other were initially explored by means of the Kaplan-Meier survivorship estimates of the mortality rates. 19 Because the average length of follow-up was about 2 years (22 months), attention was initially restricted to the estimated 2 year mortality rates. When deaths from all causes were analyzed, patients who were lost to follow-up were included in the analysis until the time at which they were lost and were then dropped from analysis (censored). When Hinkle class I deaths'8 were analyzed, patients who died from nonarrhythmic causes were included in the analysis until they died and were then censored. The goal of the Kaplan-Meier analyses was to ascertain whether frequency or repetitiveness of VPDs had effects on mortality independent of left ventricular dysfunction. When LVEF, frequency of VPDs, and repetitiveness of VPDs were analyzed jointly to obtain numerical estimates of their independent effects and to make formal statistical inferences about them, the Laird-Olivier method of survivorship analysis was applied.20 This method permitted account to be taken of a changing risk of dying with time.
The effect of each risk variable was measured by the ratio of the so-called hazard rate20 for patients with the risk factor to the hazard r4te for patients without the factor, adjusting for the other risk variables. The hazard rate is the probability that a patient will die within a short interval, given that he or she has survived to the beginning of that interval. The hazard rate is sometimes referred to as the instantaneous probability of dying. The Laird-Olivier method assumes that the hazard rate is constant within prespecified intervals for patients with the same pattern of risk factors. 20 Depending on the particular comparisons being made, the numbers of deaths vary slightly from one analysis to another. For estimating the 2 year mortality rate as a function of the frequency and repetitiveness of VPDs, the 89 deaths that occurred during the first 2 years of follow-up among the 819 patients with a 24 hr ECG were analyzed. For estimating the 2 year mortality rate as a function of both the arrhythmia variables and left ventricular dysfunction, the 80 deaths that occurred in the first 2 years of follow-up among the 766 patients with both a 24 hr ECG and a radionuclide ventriculogram were analyzed. Finally, for the Laird-Olivier survivorship analysis of mortality over the entire follow-up period, the 86 deaths that occurred in the first 3 years of follow-up among these 766 patients were analyzed.
Results Table 2 shows the relationship between frequency of VPDs and outcome and between repetitiveness of VPDs and outcome. The outcomes selected for evaluation were total mortality and the deaths due to arrhythmia (Hinkle class I).18 These are compared with the deaths due to nonarrhythmic causes (Hinkle class II or III). The rates in table 2 are Kaplan-Meier estimates of the probability of dying within the first 2 years of follow-up. The Hinkle class I deaths (arrhythmic) comprised about 60% of all the deaths in our study, a fraction that did not vary over time.
The upper portion of table 2 examines the relationship between frequency of VPDs and 2 year mortality Relationships among frequency of VPDs, repetitiveness of VPDs, and 2 year mortality after myocardial infarction (n = 819A) Hinkle The mortality rates given are the Kaplan-Meier survivorship estimates of mortality at 2 years.
AOf the 866 patients who enrolled in the study, 47 did not have a 24 hr ECG.
"The number of patients in each category at the start of follow-up.
PATHOPHYSIOLOGY AND NATURAL HISTORY-CORONARY ARTERY DISEASE estimated by Kaplan-Meier survivorship analysis. The total mortality was essentially the same for patients with no VPDs as for those with VPD frequency of greater than zero but less than one per hour. It increased somewhat for VPD frequency between one and 2.9 per hour and increased again to what appears to be a plateau at a frequency of three or more per hour. This phenomenon was found not only for total mortality but also for deaths due to arrhythmic causes. The odds of dying in any of the strata with VPDs were compared with that in the group with no VPDs for each of the three mortality end points. The odds ratios for Hinkle class I (arrhythmic) deaths and for total mortality were only slightly greater than unity for VPD frequency of greater than zero to 0.9 per hour, were somewhat greater than unity for VPD frequency from one and 2.9 per hour, and were appreciably greater than unity for higher frequencies. For the deaths due to nonarrhythmic causes (Hinkle class II or LII), the increase in the odds ratio as a function of VPD frequency was much less pronounced. The lower portion of table 2 shows the relationship between repetitiveness of VPDs and 2 year mortality (total or due to arrhythmia). Total mortality and deaths due to arrhythmia (Hinkle class I) increased substantially as a function of repetitive VPDs, but the gradient was less prominent for deaths due to nonarrhythmic causes (Hinkle class II or III). For total mortality and mortality due to arrhythmia, the odds of dying with a single VPD were only slightly higher than those of dying with no VPD. Paired VPDs, however, were associated with more than a threefold increase in the odds of dying compared with no VPD, and VPD runs were associated with a fivefold to sixfold increase in the odds of dying. Thus VPD runs have a stronger rela- TABLE 3 tionship with total mortality and deaths due to arrhythmia than do paired VPDs. The relationship between repetitive VPDs and death due to nonarrhythmic causes (Hinkle class LI or LII) was weaker, but VPD runs still had a somewhat stronger effect than paired VPDs, with no VPD as the reference category. Table 3 shows the relationships among LVEF, frequency of VPDs, and total 2 year mortality. Some of the estimated 2 year mortality rates in table 3 (as well as tables 4 and 5) are based on small numbers of patients and therefore are statistically imprecise.
There were no systematic differences within any of the categories of LVEF between total mortality for patients with no VPD and total mortality for patients with VPD frequency of greater than zero and less than one per hour. Therefore these two categories were combined into a single category of less than one VPD per hour for subsequent analyses.
With the exception only of the LVEF category of 50% and higher, the mortality rates for the three highest categories of VPD frequency were virtually identical to one another. They also tended to be higher, usually appreciably so, than the mortality rates for patients with VPD frequency less than one per hour. Therefore these three categories were combined into a single category of three or more VPDs per hour for subsequent analyses.
The mortality rate associated with VPD frequency between one and 2.9 per hour was intermediate between the rates for the lowest (< 1 VPD per hour) or the highest (¢3 VPD per hour) categories. Similar results were obtained with Hinkle class I (arrhythmic) deaths rather than total mortality as the end point. Controlling for left ventricular dysfunction, therefore, VPD frequency was significantly associated with mor-Relationships between frequency of VPDs, LVEF, and 2 year mortality rates (n = 766A) VPDs tality. A precise estimate of the effect of VPD frequency on mortality is given below with the results of the Laird-Olivier multivariate survivorship analysis.
The relationship beween LVEF and total mortality is presented in table 3. The mortality rate was 7% in both the group with LVEF of 50% or greater and the group with LVEF of 40% to 49%. The mortality rate rose slightly to 10% in the group with LVEF of 30% to 39% and then markedly to 30% in patients with LVEF of less than 30%. We dichotomized LVEF at a value of 30% because the mortality rate increased so dramatically at this value.
The 2 year mortality rate in patients with both LVEF of less than 30% and more than three VPDs per hour was 38%, whereas the 2 year mortality rate of the remaining patients was 10%. The odds of dying within 2 years were almost six times as great for the group with LVEF under 30% and more than three VPDs per hour compared with all other patients. Table 4 shows the relationships among LVEF, repetitiveness of VPDs, and total 2 year mortality. In every category of LVEF except 30% to 39%, paired VPDs were associated with a higher mortality rate than no repetitive VPDs, and VPD runs were associated with yet a higher mortality rate. A similar gradient was found with deaths due to arrhythmia (Hinkle class I) as the end point. The magnitude and significance of this gradient will be assessed below in the context of the Laird-Olivier survivorship analysis.
The joint associations among LVEF, frequency of VPDs, repetitiveness of VPDs, and 2 year mortality are shown in table 5. Each of the three variables seems to have an independent effect on mortality.
The Laird-Olivier method of survivorship analysis 
APercent values are the Kaplan-Meier survivorship estimates of 2 year mortality rates. Numbers in parentheses are the number of patients in that category at the start of follow-up. calls for the total follow-up interval of 36 months to be partitioned into discrete intervals.20 Based on our previous analysis,1' time after the index infarction was divided into two intervals, 0 to 6 months and more than 6 months. The mortality rate in the first six months of follow-up was 7% contrasted with an average mortality rate of 2% for the following five 6 month periods. Table 6 summarizes the results of applying the Laird-Olivier method of survivorship analysis to the total mortality data. Each of the three risk variables makes an independent contribution to the prediction of mortality, with ejection fraction being the most powerful predictor. Adjusting for the other variables, the instantaneous probability of dying for patients with LVEF of less than 30% was 3.5 times that for patients with LVEF of 30% or greater. The adjusted hazard ratio associated with VPD frequency of three or more per hour was lower (2.0) but significant. With respect to its associated hazard rate, the risk of dying in the category of one to 2.9 VPDs per hour was closer to that in the category of less than one VPD per hour than to that in the category of three or more VPDs per hour.
The hazard ratios associated with some aspects of VPD repetitiveness were ambiguous. VPD runs doubled the instantaneous probability of dying compared ARatio of the instantaneous probability of dying for patients in one category to that for patients in the other. All hazard ratios were calculated from the survivorship analysis.
with no repetitive VPDs, but paired VPDs were not significantly different from either no repetitive VPDs or VPD runs with respect to this probability. The effect of paired VPDs appears from the data in table 6 to be closer to that of VPD runs, but the estimates are too imprecise to warrant a definite conclusion. The hazard ratios given in table 6 are adjusted for the other factors so that they can be multiplied to estimate the ratios of hazards associated with various combinations of these risk factors. For example, the instantaneous probability of dying in patients with LVEF below 30%, more than three VPDs per hour, and VPD runs was 13 times (3.5 x 2.0 x 1.9) that in patients with none of the factors.
With respect to time since the index infarction, the instantaneous probability of dying any time during the first 6 months of follow-up was, on the average, 3.3 times that of dying any time during the subsequent 6 to 36 months.
The model that was fitted to the data to produce table 6 contained no interactions. In particular, it assumed that each of the three risk variables was as strongly associated with mortality during the first 6 months of follow-up as it was later in the follow-up period. The fit of the model to the data was good as judged by a goodness-of-fit test (X2 = 31.38, degrees of freedom = 29) . Nevertheless, a model that permits the effect of the risk variables to be different in the two periods (i.e., that includes interactions between the risk variables and time) fits the data somewhat better (interaction x2 = 10.65 , degrees of freedom = 5, p < .10). Table 7 shows the hazard ratios of the predictor variables separately within the two periods. The effect of LVEF on Vol. 69, No. 2, February 1984 mortality was much stronger in the first 6 months of follow-up (hazard ratio = 5.4) than later (hazard ratio = 1.9). The effect of VPD frequency of three or more per hour as a function of time seems to be the opposite of that for LVEF: weaker during the first 6 months of follow-up (hazard ratio = 1 . 2) and stronger later (hazard ratio = 3.7).
No consistent picture emerges with respect to the interaction between repetitiveness of VPDs and time. The effect of paired VPDs was weak in the first 6 months of follow-up (hazard ratio = 1.1) and strong later (hazard ratio = 3.8). The effect of VPD runs, however, seems equally strong in the two periods (hazard ratios of 1.9 and 2.2).
Discussion
In 1975, Schulze et al. 2 21 reported results from the first postinfarction studies of left ventricular dysfunction, ventricular arrhythmias, and death that used radionuclide methods to measure LVEF and 24 hr ECGs to assess ventricular arrhythmias. All eight deaths in their 81 patients occurred in the group with high-grade ventricular arrhythmias and LVEF below 40%.2 Because all of the deaths were in this subgroup, no assessment of the independent contributions of ventricular arrhythmia and left ventricular dysfunction was possible. Later, Ruberman et al. 3 and Moss et al.l concluded that left ventricular dysfunction and ventricular arrhythmias were independent risk factors for death after myocardial infarction. Both studies were handicapped by short ECGs (1 or 6 hr) and clinical assessment of left ventricular dysfunction.
Califf et al.22 evaluated the independent role of ventricular arrhythmias in determining survival in 611 patients with chronic coronary heart disease who were referred for cardiac catheterization. All patients had a 24 hr ECG, coronary angiogram, and left ventriculo- ARatio of the instantanous probability of dying per unit time for patients with the factor to that for patients without the factor.
BCritical ratio comparing two hazard ratios.
gram. Ventricular arrhythmias had the strongest association with subsequent mortality. There was no association between ventricular arrhythmias and coronary atherosclerosis, but a strong association was found between ventricular arrhythmias and LVEF. After adjustment was made for LVEF, no significant association remained between ventricular arrhythmias and mortality. These workers concluded that most of the association between ventricular arrhythmias and death was attributable to an association between ventricular arrhythmias and left ventricular dysfunction. There are several problems with this conclusion. First, Califf's study was not done in a postinfarction population. Second, their methods for detecting repetitive ventricular arrhythmias were subject to large errors.9 Third, the number of deaths was small, jeopardizing the type of multiple regression analysis that was done. Thus the question of independent risk from ventricular arrhythmias in the initial postinfarction years remained unresolved. Our data are by far the most extensive available to answer the questions about the relationships among left ventricular dysfunction, ventricular arrhythmias, and subsequent mortality after myocardial infarction. In our study, 766 patients had LVEF measured by radionuclide methods and a 24 hr ECG analyzed by sensitive and specific methods.' l6 In these 766 patients, 86 deaths occurred during the 3 year follow-up period. When the variables were analyzed singly, there were strong associations between death and LVEF, frequency of VPDs, or repetitiveness of VPDs. For total death and for potentially avoidable death due to arrhythmia (Hinkle class I) there was an increase in the strength of association with increasing frequency or repetitiveness of VPDs. Furthermore, when multivariate survivorship techniques were used to evaluate the independent contributions of ventricular arrhythmias and left ventricular dysfunction to postinfarction mortality, we found that VPD frequency, VPD runs, and LVEF were each independently associated with mortality, either total mortality or arrhythmia-specific mortality.
Recently there was a preliminary report from the Multicenter Investigation of the Limitation of Infarct Size (MILIS) that presented results from an analysis of the associations among LVEF, dichotomized at 40%, presence of repetitive VPDs, and 1 year mortality.23
The MILIS report included 388 patients and 25 deaths. The 24 hr ECGs were analyzed with a sensitive and specific computer system. MILIS found a much stronger univariate association between repetitive VPDs and mortality than we did. Their data also 256 showed that the association between repetitive VPDs and mortality was independent of left ventricular dysfunction. The best present evidence from this study and from MILIS favors an independent association between ventricular arrhythmias and death in the early years after myocardial infarction. Since arrhythmia as a risk factor is independent of other important postinfarction risk factors, it seems reasonable to recommend antiarrhythmic treatment as a means of reducing postinfarction risk.`4 However, no study has been done to show that antiarrhythmic drug treatment can reduce mortality after infarction. Although several preliminary or feasibility studies have been done, none has selected a group of postinfarction patients with arrhythmias and treated enough subjects to detect a moderate but significant reduction in deaths due to arrhythmia, e.g., a 30% to 40% decrease. 25 The controversy about the independence of the effect of ventricular arrhythmias on the mortality risk after myocardial infarction and discouraging results from preliminary trials with antiarrhythmic drugs has generated caution and confusion in the use of antiarrhythmic drugs after myocardial infarction. The present study indicates that ventricular arrhythmias do pose an independent risk in the first 3 years after myocardial infarction, but we cannot make any statement about the likelihood of improvement in mortality figures conditional on antiarrhythmic drug treatment. Our results do encourage the pursuit of further studies to determine the benefit/risk ratio for treatment of frequent or repetitive VPDs detected in the first few weeks after myocardial infarction. Graboys et al. 26 found that coronary heart disease patients who responded to antiarrhythmic drug treatment had a significantly better chance of surviving than those who did not. It is possible that the response to antiarrhythmic drug treatment predicted survival without being the cause of increased survivorship. The same kind of selection bias has been suggested for the antiarrhythmic drug responders to programmed ventricular stimulation. 27 Nevertheless, results such as those of Graboys et al.26 encourage the performance of further controlled drug trials to settle this issue.
Lack of significant ventricular arrhythmias in 24 hr predischarge ECGs does not preclude risk of death due to arrhythmia. Califf et al. 22 suggest that low values of LVEF (i.e., <40%) are better than 24 hr ECGs for identifying patients who are at risk for death due to arrhythmia. They recommend that patients be selected for antiarrhythmic drug trials on the basis of screening with radionuclide ventriculograms. Our data do not contradict this hypothesis. Patients with low LVEF probably have large myocardial scars and are therefore more likely to have sustained ventricular fibrillation when the ventricle is challenged by repetitive VPDs. Experimental animals with large infarcts are much more likely to develop ventricular tachycardia or fibrillation during programmed ventricular stimulation. 28 There is some evidence that programmed ventricular stimulation in man can reveal the patients who have "electrically unstable" ventricles. 29 30 Screening patients who have low LVEF with programmed ventricular stimulation may be a sensitive way to detect patients who are at very high risk of death due to arrhythmia.
Several aspects of our statistical analysis require discussion. On theoretical grounds, we expected large intercenter differences in mortality.3' However, the differences were not significant" and statistical control for enrolling center was unnecessary. We also expected that analyses of the risk variables and of time to death that took full account of their continuous nature would be more powerful than analyses that used two or three categories .32 Contrary to this expectation, each of the variables seemed to have, in the present set of data, one or two clear cut-points separating low-risk from high-risk categories.
The initial report of our study used three a priori cutpoints for time, and it was found that one cut-point was sufficient." The hazard rate during the first 3 months after hospitalization was similar to the hazard rate during the second 3 month period; the hazard rate during the period 6 to 12 months after discharge was similar to the hazard rate over the remaining follow-up period (1 to 3 years), and the former hazard rates were greatly in excess of the latter.
For the final analyses, time of follow-up was taken into account. Because time as well as the risk variables could be dichotomized or trichotomized with little loss of information in this study, the Laird-Olivier method of survival analysis was used. This method was designed for follow-up studies in which the hazard rate is constant within broad intervals.20 Had the hazard rate varied continuously with time, Cox's proportional hazards model would have been applied.32
The interaction between time and the three predictor variables used in this study is interesting and difficult to explain. LVEF was a better predictor of deaths in the first 6 months of follow-up than later. The arrhythmic variables were excellent predictors of death after 6 months but only VPD runs was a good predictor of early mortality. In one previous study there was a tendency for non-sudden deaths to predominate early after myocardial infarction.4 In our study, the proportion of deaths that were due to arrhythmia was the same in the early and late follow-up periods. One explanation of the time dependence of mortality prediction by our risk factors could be sampling error. However, in the group of 766 patients who had both a 24 hr ECG and a measurement of LVEF, 47 deaths occurred in the first 6 months of follow-up and 39 thereafter. This distribution makes sampling error an unlikely explanation. The explanation of the time interaction will have to await more refined methods for assigning deaths to functional categories.
